Terms: = Leukemia AND TBL1XR1, C21, 79718, TBLR1, IRA1, FLJ12894, DC42 AND Prognosis
4 results:
1. Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations.
Mochida K; Nakahata S; Suzuki Y; Inoue K; Moriguchi S; Yamashita A; Amano M; Morishita K
J Dermatol Sci; 2023 Feb; 109(2):80-88. PubMed ID: 36842846
[TBL] [Abstract] [Full Text] [Related]
2. Integrated molecular profiling of juvenile myelomonocytic leukemia.
Murakami N; Okuno Y; Yoshida K; Shiraishi Y; Nagae G; Suzuki K; Narita A; Sakaguchi H; Kawashima N; Wang X; Xu Y; Chiba K; Tanaka H; Hama A; Sanada M; Ito M; Hirayama M; Watanabe A; Ueno T; Kojima S; Aburatani H; Mano H; Miyano S; Ogawa S; Takahashi Y; Muramatsu H
Blood; 2018 Apr; 131(14):1576-1586. PubMed ID: 29437595
[TBL] [Abstract] [Full Text] [Related]
3. Loss of tbl1xr1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
[TBL] [Abstract] [Full Text] [Related]
4. Deletions of IKZF1 and SPRED1 are associated with poor prognosis in a population-based series of pediatric B-cell precursor acute lymphoblastic leukemia diagnosed between 1992 and 2011.
Olsson L; Castor A; Behrendtz M; Biloglav A; Forestier E; Paulsson K; Johansson B
Leukemia; 2014 Feb; 28(2):302-10. PubMed ID: 23823658
[TBL] [Abstract] [Full Text] [Related]
